These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37962427)

  • 1. Silicon-Carbon Dots-Loaded Mesoporous Silica Nanocomposites (mSiO
    Li QY; Yu X; Li X; Bao LN; Zhang Y; Xie MJ; Jiang M; Wang YQ; Huang K; Xu L
    ACS Appl Mater Interfaces; 2023 Nov; 15(47):54221-54233. PubMed ID: 37962427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold nanoparticle-capped mesoporous silica-based H
    Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
    Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. d-Enantiomeric RTHLVFFARK-NH
    Liu W; Dong X; Sun Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional carbon dots as a therapeutic nanoagent for modulating Cu(ii)-mediated β-amyloid aggregation.
    Chung YJ; Lee BI; Park CB
    Nanoscale; 2019 Mar; 11(13):6297-6306. PubMed ID: 30882825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
    Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
    Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal-Organic Frameworks Harness Cu Chelating and Photooxidation Against Amyloid β Aggregation in Vivo.
    Yu D; Guan Y; Bai F; Du Z; Gao N; Ren J; Qu X
    Chemistry; 2019 Mar; 25(14):3489-3495. PubMed ID: 30601592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory potency of 4- substituted sampangine derivatives toward Cu
    Su C; Chen Y; Chen K; Li W; Tang H
    Neurochem Int; 2020 Oct; 139():104794. PubMed ID: 32650027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors.
    Dattatray Shinde S; Kumar Behera S; Kulkarni N; Dewangan B; Sahu B
    Bioorg Med Chem; 2024 Jan; 97():117538. PubMed ID: 38056379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-target theranostic nano-composite against Alzheimer's disease fabricated by conjugating carbon dots and triple-functionalized human serum albumin.
    Wang W; Lin X; Dong X; Sun Y
    Acta Biomater; 2022 Aug; 148():298-309. PubMed ID: 35732234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ
    Sun L; Sharma AK; Han BH; Mirica LM
    ACS Chem Neurosci; 2020 Sep; 11(17):2741-2752. PubMed ID: 32786307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu
    Zhang H; Zhang C; Dong XY; Zheng J; Sun Y
    J Mol Recognit; 2018 Jun; 31(6):e2697. PubMed ID: 29318655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
    Li X; Wang W; Dong X; Sun Y
    J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy.
    Sun B; Jiang H
    J Inorg Biochem; 2024 Oct; 259():112636. PubMed ID: 38943843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
    J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity.
    Hu X; Zhang Q; Wang W; Yuan Z; Zhu X; Chen B; Chen X
    ACS Chem Neurosci; 2016 Sep; 7(9):1255-63. PubMed ID: 27433833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
    Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
    ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RTHLVFFARK-NH
    Meng J; Zhang H; Dong X; Liu F; Sun Y
    J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
    Peng YB; Tao C; Tan CP; Zhao P
    J Inorg Biochem; 2021 Nov; 224():111591. PubMed ID: 34450410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.